KPRX icon

Kiora Pharmaceuticals
KPRX

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $517K invested in Kiora Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

57% less capital invested

Capital invested by funds: $1.22M → $517K (-$699K)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$58K
2
+$11K
3
+$8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.77K

Top Sellers

1
-$47K
2
-$46.4K
3
-$333
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$329K
2
$58K
3
$48K
4
$32K
5
$13K
6
$11K
7
$8K
8
$7K
9
$7K
10
$2K
11
$1K
12
$1K
13
–